Ready for your all-in-one single cell sequencing solution?

Singleron Biotechnologies Appoints Garvan Institute of Medical Research as their Australia Certified Service Provider

Singapore, 13 January 2026 – Singleron Biotechnologies, distributed by DKSH in Australia and New Zealand, and Garvan Institute of Medical Research announced their strategic alliance, marking a significant step towards further empowering academic and pharmaceutical researchers across Australia. Both parties aim to catalyze research endeavors and accelerate drug discovery initiatives by integrating Garvan Institute’s expertise in single-cell and bioinformatics, with Singleron’s innovative multi-omics single-cell platform.

As a certified service provider, Garvan Institute will deliver carefully curated single-cell multi-omics solution by utilizing Singleron’s cutting-edge products. Along with Singleron’s unique solutions, this alliance tailors to meet the diverse needs of Garvan’s academic and biopharmaceutical clients.

Chris O’Keeffe, Cellular Genomics Lead from Garvan Institute, emphasizes: “Sharing the commitment to scientific excellence and customer care, this strategic alliance signifies a pivotal step towards addressing existing challenges for academia and biopharmaceutical clients by leveraging our complementary strengths.”

The Garvan Institute of Medical Research stands as a cornerstone of life science innovation in Australia and a major strategic research partner and customer for Singleron and DKSH. For single-cell users, this translates into accessible and affordable unique single-cell multi-omics solutions in Australia that comes with consistent quality service, backed by Garvan Institute’s team of certified experts, alongside with Singleron’s and DKSH’s support.

About Singleron

Singleron Biotechnologies advances precision medicine and human health through pioneering single cell multi-omics solutions. Its current product portfolio includes high throughput instruments for automated single cell processing and tissue dissociation, reagents, bioinformatics software, and a comprehensive single cell knowledge base.

Founded in 2018, Singleron operates globally with offices, laboratories, and manufacturing facilities in Germany, Singapore, China, and the US. Its products are used in more than 3,000 laboratories in hospitals, research institutes, and pharmaceutical companies.

Follow us on LinkedIn for real-time updates.

About Garvan Institute of Medical Research

As part of the world-renowned Garvan Institute of Medical Research, the Garvan Genomics Platform is dedicated to advancing medical research through cutting-edge genomic technologies. Our institute is globally recognized for pioneering discoveries that improve human health.

At the Garvan Genomics Platform, we excel in streamlining your sample’s journey from tissue dissociation to cell sorting (FACS), bulk and single-cell RNAseq or spatial transcriptomics, to sequencing and data analysis—all in one integrated platform. We specialize in methods adding unique layers of additional data to transcriptomic readouts, such as time-resolved transcriptomics (DynaSCOPE), single cell methylation, targeted single cell RNAseq panels (EBC, microbial, blood cancer) and full cardiomyocyte live cell capture.

Our goal is to provide unparalleled insights into cellular function and tissue architecture, driving breakthroughs in understanding complex biological systems.